Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole

T. J. Walsh, B. Moriyama, S. R. Penzak, T. E. Klein, K. E. Caudle

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole'. Together they form a unique fingerprint.